Fermenta Biotech Limited reported earnings results for the third quarter and nine months ended December 31, 2023. For the third quarter, the company reported sales was INR 989.67 million compared to INR 548.62 million a year ago. Revenue was INR 1,014.91 million compared to INR 557.62 million a year ago. Net income was INR 98.49 million compared to net loss of INR 365.31 million a year ago. Basic earnings per share from continuing operations was INR 3.41 compared to basic loss per share from continuing operations of INR 12.66 a year ago. Diluted earnings per share from continuing operations was INR 3.41 compared to diluted loss per share from continuing operations of INR 12.66 a year ago.
For the nine months, sales was INR 2,383.23 million compared to INR 2,447.79 million a year ago. Revenue was INR 2,447.5 million compared to INR 2,522.14 million a year ago. Net loss was INR 161.19 million compared to INR 469.63 million a year ago. Basic loss per share from continuing operations was INR 5.59 compared to INR 16.27 a year ago. Diluted loss per share from continuing operations was INR 5.59 compared to INR 16.27 a year ago.